AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34378863 — intervention group
Group type: COMPARATOR
Intervention: Conventional-dose ergocalciferol (standard dosage according to K/DOQI guidelines) for 8 weeks
Number of subjects: 70
Study 34378863 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose ergocalciferol (for subgroup with serum 25[OH]D <20 ng/ml)
Number of subjects: 70
Study 34378863 — intervention group
Group type: COMPARATOR
Intervention: Conventional-dose ergocalciferol (for subgroup with serum 25[OH]D <20 ng/ml)
Number of subjects: 70
Study 33908233 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy, stabilometric trainings, neuropsychological tasks
Number of subjects: 52
Study 33908233 — intervention group
Group type: COMPARATOR
Intervention: Intense physical activity with cyclic exercises, biomechanotherapy
Number of subjects: 52
Study 32450709 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide (H2O2) clusters at concentrations of 1.0 mM to 9.8 M
Number of subjects: 0
Study 32450709 — intervention group
Group type: EXPERIMENTAL
Intervention: X-ray irradiation of nitroxyl radical solutions
Number of subjects: 0
Study 32450709 — intervention group
Group type: EXPERIMENTAL
Intervention: UVB irradiation at 12000 μW/cm2 for 2 min
Number of subjects: 0
Study 32450709 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of K3[Fe(CN)6] or FeCl3 to the reaction mixture
Number of subjects: 0
Study 34996424 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavioral therapy (ICBT) for two menstrual cycles
Number of subjects: 92
Study 34996424 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 92
Study 36403542 — intervention group
Group type: EXPERIMENTAL
Intervention: Cream with nanoparticles containing vitamin E
Number of subjects: 40
Study 36403542 — intervention group
Group type: COMPARATOR
Intervention: Cream without nanoparticles or vitamin E (Control 1)
Number of subjects: 40
Study 36403542 — intervention group
Group type: COMPARATOR
Intervention: Cream with nanoparticles without vitamin E (Control 2)
Number of subjects: 40
Study 32902766 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-hybride resin-based composite (RBC)
Number of subjects: 33
Study 32902766 — intervention group
Group type: COMPARATOR
Intervention: Resin modified glass ionomer cement (RMGIC)
Number of subjects: 33
Study 35028688 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccinium fruit supplements
Number of subjects: 20
Study 35063965 — intervention group
Group type: EXPERIMENTAL
Intervention: venetoclax + azacitidine
Number of subjects: 64
Study 35063965 — intervention group
Group type: COMPARATOR
Intervention: azacitidine
Number of subjects: 64
Study 34342251 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) and Mixed Reality (MR) psychotherapies
Number of subjects: 0
Study 32072792 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar stabilization exercise protocol
Number of subjects: 20
Study 32072792 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching exercise protocol
Number of subjects: 20
Study 36460535 — intervention group
Group type: EXPERIMENTAL
Intervention: FD MVA-BN vaccine (3 lots)
Number of subjects: 1129
Study 33650407 — intervention group
Group type: EXPERIMENTAL
Intervention: Aviron Rapid® + standard symptomatic therapy
Number of subjects: 0
Study 33650407 — intervention group
Group type: COMPARATOR
Intervention: Placebo + standard symptomatic therapy
Number of subjects: 0
Study 32810147 — intervention group
Group type: EXPERIMENTAL
Intervention: Couples' UBL intervention
Number of subjects: 6770
Study 32810147 — intervention group
Group type: EXPERIMENTAL
Intervention: Women's UBL intervention
Number of subjects: 6770
Study 32810147 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 6770
Study 36269054 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding Counseling (5244)
Number of subjects: 166
Study 36269054 — intervention group
Group type: COMPARATOR
Intervention: Usual education plus nursing intervention not related to breastfeeding
Number of subjects: 166
Study 34426507 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma adiponectin levels of 19.2 μg/mL (3rd quartile)
Number of subjects: 756219
Study 34426507 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma adiponectin levels of 13.9 μg/mL (2nd quartile)
Number of subjects: 756219
Study 34426507 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma adiponectin levels of 9.2 μg/mL (1st quartile)
Number of subjects: 756219
Study 34426507 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 μg/mL lower plasma adiponectin
Number of subjects: 756219
Study 34426507 — intervention group
Group type: EXPERIMENTAL
Intervention: One-sample MR (5 genetic variants)
Number of subjects: 756219
Study 34426507 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-sample MR (10 genetic variants)
Number of subjects: 756219
Study 33129304 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide
Number of subjects: 106
Study 33129304 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study 34611811 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferred consent in the ULTRA trial
Number of subjects: 135
Study 34611811 — intervention group
Group type: EXPERIMENTAL
Intervention: Preferred consent procedure for the ULTRA trial
Number of subjects: 135
Study 34611811 — intervention group
Group type: EXPERIMENTAL
Intervention: Trust in physicians and scientific research
Number of subjects: 135
Study 34611811 — intervention group
Group type: EXPERIMENTAL
Intervention: Physicians' agreement with deferred consent in the ULTRA trial
Number of subjects: 135
Study 35324322 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital literacy assessment tool
Number of subjects: 161
Study 35324322 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional consent process for tech-savvy individuals
Number of subjects: 161
Study 35324322 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored consent process for individuals with weaker skills
Number of subjects: 161
Study 35858825 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-actuated molecular-electrochemical system for detecting SARS-CoV-2 RNAs
Number of subjects: 0
Study 35858825 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-blind testing and 10-in-1 pooled testing
Number of subjects: 0
Study 33606921 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 0
Study 33606921 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32932482 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomization of pixel positions in hologram display using a liquid crystal modulator
Number of subjects: 0
Study 32932482 — intervention group
Group type: EXPERIMENTAL
Intervention: Photo-magnetic transparent cobalt-doped yttrium iron garnet
Number of subjects: 0
Study 32932482 — intervention group
Group type: EXPERIMENTAL
Intervention: Micromirror-driven raster scanning of femtosecond pulses
Number of subjects: 0
Study 32932482 — intervention group
Group type: EXPERIMENTAL
Intervention: Recorded holographic patterns
Number of subjects: 0
Study 33998882 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) chewing gum (50 mg)
Number of subjects: 32
Study 33998882 — intervention group
Group type: COMPARATOR
Intervention: Placebo chewing gum
Number of subjects: 32
Study 32623524 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozonated water mouthwash
Number of subjects: 42
Study 32623524 — intervention group
Group type: COMPARATOR
Intervention: Bidistilled water mouthwash (Control)
Number of subjects: 42
Study 35644221 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 0
Study 35644221 — intervention group
Group type: COMPARATOR
Intervention: Ticagrelor
Number of subjects: 0
Study 34107989 — intervention group
Group type: EXPERIMENTAL
Intervention: Panoramic radiography (PAN) analysis prediction equations (PAN-D)
Number of subjects: 292
Study 34107989 — intervention group
Group type: COMPARATOR
Intervention: Cone-beam computed tomography (CBCT)
Number of subjects: 292
Study 35420695 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic adjuvant pelvic radiation to a dose of 30 Gy in 5 fractions administered every other day or once weekly
Number of subjects: 61
Study 33579257 — intervention group
Group type: EXPERIMENTAL
Intervention: Leaflet provided with hypothetical screening results (intervention group)
Number of subjects: 972
Study 33579257 — intervention group
Group type: COMPARATOR
Intervention: No leaflet provided (control group)
Number of subjects: 972
Study 35797111 — intervention group
Group type: EXPERIMENTAL
Intervention: PiCCO-guided fluid resuscitation
Number of subjects: 78
Study 33649979 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic enoxaparin (4000 IU)
Number of subjects: 436
Study 33649979 — intervention group
Group type: COMPARATOR
Intervention: Higher dosing regimen (> 4000 IU)
Number of subjects: 436
Study 34027769 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness group
Number of subjects: 74
Study 34027769 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 74
Study 33170321 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating Tumor-Associated Cells (C-TACs)
Number of subjects: 5090
Study 35705346 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-driven intervention with study buddy recruitment and standard retention outreach
Number of subjects: 0
Study 35705346 — intervention group
Group type: COMPARATOR
Intervention: Standard retention outreach by study staff
Number of subjects: 0
Study 35196114 — intervention group
Group type: EXPERIMENTAL
Intervention: InnoSpire Go mesh nebulizer
Number of subjects: 17
Study 35196114 — intervention group
Group type: COMPARATOR
Intervention: Compressor driven jet nebulizer
Number of subjects: 17
Study 34912512 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B6 (80 mg)
Number of subjects: 81
Study 34912512 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 33089287 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital clear aligners (experimental group)
Number of subjects: 33
Study 33089287 — intervention group
Group type: COMPARATOR
Intervention: Fixed appliances (control group)
Number of subjects: 33
Study 35334856 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketogenic Formula (KF)
Number of subjects: 20
Study 32180212 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual intercourse at least three times a week
Number of subjects: 225
Study 32180212 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg/d
Number of subjects: 225
Study 32180212 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy alone
Number of subjects: 225
Study 36463724 — intervention group
Group type: EXPERIMENTAL
Intervention: GRASP (GRoup trAining for Social skills in Psychosis) plus treatment-as-usual (TAU)
Number of subjects: 48
Study 36463724 — intervention group
Group type: COMPARATOR
Intervention: TAU alone
Number of subjects: 48
Study 33875426 — intervention group
Group type: EXPERIMENTAL
Intervention: Clofazimine 300 mg daily for 3 days, followed by 100 mg daily for 11 days
Number of subjects: 15
Study 33875426 — intervention group
Group type: EXPERIMENTAL
Intervention: Clofazimine (loading doses of 200 and 300 mg)
Number of subjects: 15
Study 33118436 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambivalent sexism and victim's gender role
Number of subjects: 139
Study 33118436 — intervention group
Group type: COMPARATOR
Intervention: Traditional gender role video
Number of subjects: 139
Study 33118436 — intervention group
Group type: COMPARATOR
Intervention: Nontraditional gender role video
Number of subjects: 139
Study 33481787 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine group
Number of subjects: 739
Study 33481787 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 739
Study 33481787 — intervention group
Group type: EXPERIMENTAL
Intervention: BEN presence
Number of subjects: 739
Study 33481787 — intervention group
Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 739
Study 33481787 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis use
Number of subjects: 739
Study 35671089 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone ownership
Number of subjects: 3299
Study 35671089 — intervention group
Group type: EXPERIMENTAL
Intervention: Reported daily use of mobile phones
Number of subjects: 3299
Study 35671089 — intervention group
Group type: EXPERIMENTAL
Intervention: Comfort receiving screening results via SMS
Number of subjects: 3299
Study 35671089 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher education level
Number of subjects: 3299
Study 35671089 — intervention group
Group type: EXPERIMENTAL
Intervention: Missing work to attend screening
Number of subjects: 3299
Study 35671089 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous cervical cancer screening
Number of subjects: 3299
Study 35671089 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment uptake
Number of subjects: 3299
Study 35671089 — intervention group
Group type: EXPERIMENTAL
Intervention: Sharing a mobile phone with partner/spouse
Number of subjects: 3299
Study 35671089 — intervention group
Group type: COMPARATOR
Intervention: Type of notification method (SMS, phone call, home visit)
Number of subjects: 3299
Study 32772097 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT+BA+CM
Number of subjects: 120
Study 32772097 — intervention group
Group type: COMPARATOR
Intervention: CBT+BA
Number of subjects: 120
Study 32772097 — intervention group
Group type: EXPERIMENTAL
Intervention: CM
Number of subjects: 120
Study 36002111 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative insights from patients regarding dietary changes post-diagnosis
Number of subjects: 29
Study 36002111 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical Influences
Number of subjects: 29
Study 36002111 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Beliefs
Number of subjects: 29
Study 36002111 — intervention group
Group type: EXPERIMENTAL
Intervention: Static Diets
Number of subjects: 29
Study 36002111 — intervention group
Group type: EXPERIMENTAL
Intervention: Navigating External Influences
Number of subjects: 29
Study 33504277 — intervention group
Group type: EXPERIMENTAL
Intervention: Re-randomization tests
Number of subjects: 0
Study 33504277 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimization and permuted blocks
Number of subjects: 0
Study 33504277 — intervention group
Group type: COMPARATOR
Intervention: Asymptotic tests
Number of subjects: 0
Study 32402931 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 506
Study 32402931 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 506
Study 32729286 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance-Based Financing (PBF)
Number of subjects: 11010
Study 32729286 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance-Based Financing (PBF) combined with equity measures
Number of subjects: 11010
Study 32729286 — intervention group
Group type: COMPARATOR
Intervention: Standard PBF
Number of subjects: 11010
Study 33978698 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathoracic anastomosis
Number of subjects: 245
Study 33978698 — intervention group
Group type: COMPARATOR
Intervention: Cervical anastomosis
Number of subjects: 245
Study 32778102 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease-specific PROM
Number of subjects: 0
Study 32778102 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic PROM
Number of subjects: 0
Study 32778102 — intervention group
Group type: EXPERIMENTAL
Intervention: Both disease-specific and generic PROMs
Number of subjects: 0
Study 32778102 — intervention group
Group type: COMPARATOR
Intervention: Usual care (no PROMs)
Number of subjects: 0
Study 35605599 — intervention group
Group type: EXPERIMENTAL
Intervention: VNeST plus anodal tDCS stimulation of left inferior frontal gyrus (IFG)
Number of subjects: 3
Study 35605599 — intervention group
Group type: COMPARATOR
Intervention: VNeST plus sham stimulation
Number of subjects: 3
Study 32998184 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal migration of children
Number of subjects: 791
Study 32998184 — intervention group
Group type: COMPARATOR
Intervention: No migration of children
Number of subjects: 791
Study 36285573 — intervention group
Group type: COMPARATOR
Intervention: Standard bolus
Number of subjects: 25
Study 36285573 — intervention group
Group type: EXPERIMENTAL
Intervention: Split bolus 70/30 with 20% increment
Number of subjects: 25
Study 34383903 — intervention group
Group type: EXPERIMENTAL
Intervention: Pecan consumption (68 g) as part of a free-living diet (ADD group, n = 16)
Number of subjects: 56
Study 34383903 — intervention group
Group type: EXPERIMENTAL
Intervention: Pecan substitution (68 g) for isocaloric foods (SUB group, n = 18)
Number of subjects: 56
Study 34383903 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 18)
Number of subjects: 56
Study 32070409 — intervention group
Group type: EXPERIMENTAL
Intervention: Total ankle replacement
Number of subjects: 0
Study 32070409 — intervention group
Group type: COMPARATOR
Intervention: Ankle arthrodesis
Number of subjects: 0
Study 34980232 — intervention group
Group type: EXPERIMENTAL
Intervention: ANC counseling plus BEP supplement
Number of subjects: 1836
Study 34980232 — intervention group
Group type: EXPERIMENTAL
Intervention: ANC counseling plus BEP supplement plus 2 doses azithromycin
Number of subjects: 1836
Study 34980232 — intervention group
Group type: EXPERIMENTAL
Intervention: ANC counseling plus BEP supplement plus daily single dose of nicotinamide and choline
Number of subjects: 1836
Study 34980232 — intervention group
Group type: COMPARATOR
Intervention: ANC counseling only (control group)
Number of subjects: 1836
Study 35799221 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage at cervical dilatation of 7 cm for 20 minutes
Number of subjects: 60
Study 35799221 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage at cervical dilatation of 5 cm for 20 minutes
Number of subjects: 60
Study 35799221 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage at cervical dilatation of 9 cm for 20 minutes
Number of subjects: 60
Study 35799221 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage group
Number of subjects: 60
Study 35799221 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine care without massage)
Number of subjects: 60
Study 32116199 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 8mg
Number of subjects: 60
Study 32116199 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron 4mg
Number of subjects: 60
Study 33175440 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant and early childhood mental health consultation (IECMHC)
Number of subjects: 1195
Study 33175440 — intervention group
Group type: COMPARATOR
Intervention: Technical assistance (TA)
Number of subjects: 1195
Study 33175440 — intervention group
Group type: COMPARATOR
Intervention: BehaviorHelp (BH) system overall
Number of subjects: 1195
Study 32032196 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosthetic mesh
Number of subjects: 70
Study 32032196 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 70
Study 34669637 — intervention group
Group type: EXPERIMENTAL
Intervention: 22-point risk score based on multivariable model for predicting postoperative pneumonia (POP)
Number of subjects: 3853
Study 35321739 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction-aided decisions during bDMARD tapering
Number of subjects: 279
Study 32618436 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy with high-risk regimens including cisplatin or carboplatin and doxorubicin (19 patients), or cisplatin or carboplatin alone (3 patients)
Number of subjects: 22
Study 35926202 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical dilators with misoprostol
Number of subjects: 347
Study 35926202 — intervention group
Group type: COMPARATOR
Intervention: Misoprostol alone
Number of subjects: 347
Study 33531152 — intervention group
Group type: COMPARATOR
Intervention: Multilayer cage rearing (MC)
Number of subjects: 2400
Study 33531152 — intervention group
Group type: EXPERIMENTAL
Intervention: Narasin inclusion in diets
Number of subjects: 2400
Study 33531152 — intervention group
Group type: COMPARATOR
Intervention: Multilayer cage (MC) and plastic net (PN) rearing systems
Number of subjects: 2400
Study 33531152 — intervention group
Group type: COMPARATOR
Intervention: Multilayer cage (MC) compared with flooring litter (FL)
Number of subjects: 2400
Study 33531152 — intervention group
Group type: EXPERIMENTAL
Intervention: Flooring litter (FL)
Number of subjects: 2400
Study 33531152 — intervention group
Group type: EXPERIMENTAL
Intervention: Narasin combined with multilayer cage (MC)
Number of subjects: 2400
Study 33531152 — intervention group
Group type: EXPERIMENTAL
Intervention: Plastic net (PN)
Number of subjects: 2400
Study 33531152 — intervention group
Group type: COMPARATOR
Intervention: Multilayer cage (MC)
Number of subjects: 2400
Study 36355640 — intervention group
Group type: EXPERIMENTAL
Intervention: Just-in-time adaptive intervention (JITAI) with personalized pushes (text-based notifications)
Number of subjects: 70
Study 36355640 — intervention group
Group type: COMPARATOR
Intervention: Control group (no JITAI)
Number of subjects: 70
Study 34544324 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin and exercise therapy
Number of subjects: 40
Study 34544324 — intervention group
Group type: COMPARATOR
Intervention: Exercise therapy alone
Number of subjects: 40
Study 35654972 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide (a GLP‐1 receptor agonist)
Number of subjects: 300
Study 35654972 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 35654972 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 300
Study 33872345 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 26
Study 33872345 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 26
Study 33872345 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 26
Study 32727733 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% fluence rate of photodynamic therapy (PDT)
Number of subjects: 51
Study 32727733 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% fluence rate of photodynamic therapy (PDT)
Number of subjects: 51
Study 32727733 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% fluence rate of photodynamic therapy (PDT)
Number of subjects: 51
Study 32450215 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D video-system
Number of subjects: 70
Study 32450215 — intervention group
Group type: COMPARATOR
Intervention: 2D video-system
Number of subjects: 70